Evidence map›Paper›PMID 30103549›Full record

ReviewViruses2018

A Systems Approach to Study Immuno- and Neuro-Modulatory Properties of Antiviral Agents.

Eva Zusinaite, Aleksandr Ianevski, Diana Niukkanen, Minna M Poranen, Magnar Bjørås, Jan Egil Afset, Tanel Tenson, Vidya Velagapudi, Andres Merits, Denis E Kainov

Abstract readReview
In one paragraph

Review in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eva ZusinaiteInstitute of Technology, University of Tartu, 50090 Tartu, Estonia. eva.zusinaite@ut.ee.
Aleksandr IanevskiNorwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway. aleksandr.ianevski@helsinki.fi.
Diana NiukkanenInstitute of Technology, University of Tartu, 50090 Tartu, Estonia. dianka96-96@mail.ru.
Minna M PoranenMolecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, 00014 Helsinki, Finland. minna.poranen@helsinki.fi.
Magnar BjøråsNorwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway. magnar.bjoras@ntnu.no.
Jan Egil AfsetNorwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway. jan.afset@ntnu.no.
Tanel TensonInstitute of Technology, University of Tartu, 50090 Tartu, Estonia. tanel.tenson@ut.ee.
Vidya VelagapudiInstitute Molecular Medicine Finland (FIMM), University of Helsinki, 00014 Helsinki, Finland. vidya.velagapudi@helsinki.fi.
Andres MeritsInstitute of Technology, University of Tartu, 50090 Tartu, Estonia. andres.merits@ut.ee.
Denis E KainovInstitute of Technology, University of Tartu, 50090 Tartu, Estonia. denis.kainov@helsinki.fi.ORCID 0000-0001-7716-6955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are dozens of approved, investigational and experimental antiviral agents. Many of these agents cause serious side effects, which can only be revealed after drug administration. Identification of the side effects prior to drug administration is challenging. Here we describe an ex vivo approach for studying immuno- and neuro-modulatory properties of antiviral agents, which may be associated with potential side effects of these therapeutics. The current approach combines drug toxicity/efficacy tests and transcriptomics, which is followed by mRNA, cytokine and metabolite profiling. We demonstrated the utility of this approach with several examples of antiviral agents. We also showed that the approach can utilize different immune stimuli and cell types. It can also include other omics techniques, such as genomics and epigenomics, to allow identification of individual markers associated with adverse reactions to antivirals with immuno- and neuro-modulatory properties.

Indexed as

Antiviral AgentsCytokinesEpigenomicsGene Expression ProfilingGenomicsHumansImmune SystemMetabolomicsNervous SystemPrecision MedicineSystems BiologyAntiviral AgentsCytokinesantiviral agentdrug side effectdrug targetinnate immunityprecision medicinesystems biologyvirus

Identifiers

PMID30103549
PMCPMC6116047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.